Tempus AI, Inc. (TEM)
NASDAQ: TEM · IEX Real-Time Price · USD
35.00
+4.17 (13.53%)
At close: Jun 28, 2024, 4:00 PM
34.52
-0.48 (-1.37%)
After-hours: Jun 28, 2024, 7:58 PM EDT
Tempus AI Market Cap
Tempus AI has a market cap or net worth of $5.78 billion as of June 28, 2024.
Market Cap
5.78B
Enterprise Value
6.17B
1-Year Change
n/a
Ranking
Category
Stock Price
$35.00
Market Cap Chart
Since the IPO on June 14, 2024, Tempus AI's market cap has decreased from $6.11B to $5.78B, a decrease of -5.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2024 | 5.09B | 11.87% |
| Jun 26, 2024 | 4.55B | 10.42% |
| Jun 25, 2024 | 4.12B | -1.38% |
| Jun 24, 2024 | 4.18B | -11.63% |
| Jun 21, 2024 | 4.73B | 5.06% |
| Jun 20, 2024 | 4.50B | -10.12% |
| Jun 18, 2024 | 5.01B | -16.86% |
| Jun 17, 2024 | 6.02B | -1.41% |
| Jun 14, 2024 | 6.11B | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acadia Healthcare Company | 6.27B |
| Cytokinetics | 6.21B |
| Madrigal Pharmaceuticals | 5.97B |
| Glaukos | 5.96B |
| Viking Therapeutics | 5.85B |
| Lantheus Holdings | 5.57B |
| Summit Therapeutics | 5.48B |
| Organon & Co. | 5.32B |